GlassScriptPhysician profile
Stephanie Brashear
NPI 1245539998
$658.59
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.51 · 2022: $16.48 · 2023: $347 · 2024: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $183.77 | 2023-2024 | Vraylar, Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $74.35 | 2023-2024 | Veozah |
| Sumitomo Pharma America, INC. | $55.02 | 2023-2024 | Myfembree, Gemtesa |
| Otsuka America Pharmaceutical, INC. | $48.24 | 2023 | Rexulti |
| Novo Nordisk INC | $35.29 | 2023 | Wegovy, Rybelsus, Ozempic |
| Exact Sciences Corporation | $33.25 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $32.15 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.12 | 2023 | |
| Gynesonics, INC. | $28.14 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Regeneron Healthcare Solutions, INC. | $22.46 | 2019 | |
| Supernus Pharmaceuticals, INC. | $19.88 | 2023 | Qelbree |
| Organon LLC | $17.01 | 2024 | |
| Urovant Sciences INC | $16.48 | 2022 | |
| Glaxosmithkline, LLC. | $15.95 | 2023 | Trelegy Ellipta |
| Sanofi-Aventis U.S. LLC | $15.05 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $15.04 | 2023 | Slynd |
| Alexion Pharmaceuticals, INC. | $14.39 | 2023 | Strensiq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Brashear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.